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To investigate whether hydroxylated metabolites of benzene may be responsible for the
amplification of granulocyte-macrophage progenitor cells (GM-CFC) observed in mice that inhale
benzene, groups of six C57BL6 mice were injected with hydroquinone (HQ) (75 mg/kg) or HQ (50
mg/kg) plus phenol (PHE) (50 mg/kg) twice daily for 11 days. Deviations in blood leukocyte and
erythrocyte levels by up to one-third were noted in the treated groups; however, the peripheral
blood differential counts were unchanged. Although no changes in bone marrow cellularity were
observed in mice treated with HQ, cellularity was decreased by a factor of two in the mice that
had received HQ plus PHE. The number of GM-CFC per femur was doubled in both treated
groups. In vitro experiments using the murine multipotent hematopoietic progenitor cells FDCP
mix also showed a duplication of GM-CFC formation in the presence of HQ at concentrations
between 106 M and 10-10 M. When HQ and PHE were present at equimolar concentrations,
significantly increased colony formation was still observed with 10-12 M of metabolites. The
effect was independent of the concentration of GM-colony-stimulating factor used. We suggest
that HQ is a major mediator of the stimulatory effect of benzene on GM-CFC in mice. In addition,
the in vitro data indicate that a direct effect on GM-CFC is involved. - Environ Health Perspect
104(Suppl 6):1271-1274 (1996)
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Introduction
Benzene has been well recognized as a
hazardous industrial chemical for many
years (1). Exposure to benzene has been
associated with increased incidence ofblood
dyscrasias, including cytopenias, aplastic
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anemias, myelodysplastic syndromes, and
leukemias (2-4). Damage to the hema-
topoietic system by benzene has been pre-
dominantly linked to the formation and
accumulation in bone marrow ofhydroxy-
lated derivatives such as hydroquinone
(HQ) and catechol (5,6). This was shown
to be due to the conversion of phenol
(PHE), the major in vivometabolite ofben-
zene, by myeloid cell-derived myeloperoxi-
dase in the bone marrow (7). Oxidation of
HQ to p-benzoquinone (BQ) via a semi-
quinone intermediate is considered a key
step towards the generation oftoxic inter-
mediates in bone marrow (8); however,
open-ring products such as trans-trans-
mucondialdehyde may also be responsible
for cytotoxic damage following benzene
exposure (9,10).
Types of permanent DNA damage
caused by benzene or its metabolites
include structural chromosome aberrations,
aneuploidy, sister chromatid exchange,
micronuclei (11), and gene mutations
(12). Hydroquinone and BQ have been
shown to result in the formation of DNA
adducts, whose structures have been char-
acterized in part (13). Other studies have
looked at short-term effects of hydroxy-
lated benzene metabolites on different cel-
lular compartments of bone marrow, i.e.,
different types ofstroma cells, hematopoi-
etic stem cells, progenitor cells, and matur-
ing cells of different blood cell lineages.
Mainly, marrow-adherent cells, including
mononuclear phagocytes, have been
defined as targets ofhematopoietic damage
by benzene (14-17).
Benzene application augments precursor
cells of granulocyte-macrophage (GM)
lineage in bone marrow ofmice during and
after chronic inhalation (18). Work by
Irons and colleagues (19) demonstrated a
synergistic effect ofhydroquinone (HQ) on
granulocyte-macrophage progenitor cells
(GM-CFC) in vitro. Analysis ofcytofluoro-
metrically sorted bone marrow cells and
plating at low cell numbers demonstrated
that this is a direct-i.e., not stroma cell-
mediated-effect on GM-CFC.
We investigated whether HQadminis-
tered in vivo could reproduce the increase
in GM-CFC seen in mice that inhaled
benzene chronically (18). We used the
protocol that had been reported by
Eastmond et al. (20) to reproduce, after ip
injection ofHQ and PHE, the decrease in
bone marrow cellularity associated with
chronic inhalation of benzene. To deter-
mine if this is a direct effect on the prog-
enitor cells, we conducted analogous in
vitroexperiments.
Materials and Methods
Chemicals
Hydroquinone, CAT, and PHE (research
grade) were purchased from Sigma Chemical
Co. (Munich, Germany). Substances were
dissolved fresh in phosphate-buffered saline
(PBS) and added to the cell cultures at 1 or
0.33% v/v. For treatment ofmice, chemi-
cals were dissolved in PBS, buffered to a
pH of 7.4 with 100 mM Tris-phosphate,
sterile filtered, aliquoted, and kept frozen
at -70°C until use. The concentration was
adjusted for a constant injection volume of
0.2 ml per mouse.
Mice
Male B6D2F1 mice, 6 to 10 weeks old,
were obtained from the Deutsche Tierver-
suchsanstalt (Hannover, Germany). They
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were allowed standard rodent food and
water ad libitum throughout the studies.
Mice were treated and kept in groups of
six. Injections (50-75 mg/kg/day in 0.2 ml
solvent, ip) were administered during the
day twice daily, with at least a 6-hr interval
between injections, following the schedule
ofEastmond et al. (20). On day 12 ofthe
trials, blood smears were obtained from the
tail vein, animals were killed by cervical
dislocation, and bone marrow cells from
femora were prepared according to stan-
dard methods (21).
Cytology
Blood and bone marrow smears were per-
formed on glass slides, stained with May-
Grunwald-Giemsa (Merck, Darmstadt,
Germany) and evaluated microscopically.
Cell counts were performed in 0.3% acetic
acid for white blood cells or in 1% methyl-
ene blue in PBS for red cells.
FDCP-mix Cells
Factor-dependent cells Paterson (FDCP)-
mix cells (22) were kept in Iscove's
modified Dulbecco's medium (IMDM)
(GIBCO, Paisley, UK) supplemented with
20% pre-selected horse serum (Sigma) and
2% mIL-3 conditioned medium (23). Cells
were incubated in a humidified atmosphere
at 37°C and 5% CO2. Blast morphology
was controlled using cytospin preparations
at regular intervals. For agar plating, cells
were washed twice in IMDM and resus-
pended at 5000 cells/ml in IMDM contain-
ing 20% fetal calfserum (FCS) (GIBCO),
10% (v/v) of 100 mg/ml bovine serum
albumin ([BSA]; Boehringer Mannheim)
and cytokines dissolved in PBS/1% BSA.
Recombinant mouse GM-CSF and inter-
leukin-3 (IL-3) were also from Boehringer
Mannheim. A mixture ofcells, growth fac-
tors, and chemicals was preincubated for
30 min at 37°C, after which 10% v/v of
3.3% agar in H20 was added; the resulting
plating mix was allowed to gel in 1-ml cul-
ture dishes (NUNC, Wiesbaden, Germany)
before incubation in a humidified atmos-
phere at 37°C and 5% CO2 in air. Colonies
were evaluated under a light microscope on
day 7. Colonies containing more than 30
cells were scored positive.
Results
Effec inMiceInjectedwith
Hydroquinone andPhenol
Groups of six mice were injected ip twice
dailywith PBS, HQ, orequimolar HQand
PHE. Animal weights remained constant
Table 1. Blood and bone marrow cellular parameters following exposure of mice to hydroquinone or hydroquinone
plus phenol.
Cells, no.
Control Hydroquinone Hydroquinone + phenol
Blood leukocytes, x105/ml 49.4 ± 8.0w 69.5 ± 18.6 51.8 ± 27.8
Blood erythrocytes, xl07/ml 33.0 ± 5.8 36.3 ± 13.4 24.7 ± 8.3
Bone marrow cellularity, x105/femur 64.0 ± 14.1 59.5 ± 12.0 36.8 ± 9.6b
"Values are means ±SD of six mice. bStatistically differentfrom control using Student's t-test(p<0.01).
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Figure 1. Influence of HQ and PHE on bone marrow
GM-CFC content in mice. Total femur GM-CFC content
is shown in control mice, HQ-treated mice and HQ +
PHE-treated mice. Each dot represents the mean value
of three measurements from the combined contents of
both femurs of one mouse. The horizontal line indi-
cates the means of all animals within one group.
Wilcoxon's rank test showed statistical significance in
the differences between control and HQ-treated, and
controls and HQ- and PHE-treated groups(p<0.005).
throughout the treatment period (25 g). No
abnormal behavior was registered, except
for some minutes ofbehavioral irritation
after the first dose in animals that received
combined HQ and PHE. Blood leukocyte
and erythrocyte counts were relatively
unchanged between the treated and control
groups, except for an anemia in the HQ +
PHE group, and a slight leukocytosis in
the HQ-treated group, which was not sta-
tistically significant (Table 1). Bone mar-
row cellularity was reduced upon treatment
with HQ + PHE, but not in HQ-treated
animals (Table 1). No changes in the blood
differential cell count were observed (data
not shown). When femur bone marrow
cells were assayed for GM-CFC, all mice in
the treated groups displayed elevated num-
bers ofGM-CFC per femur in comparison
with the levels of the control animals
(Figure 1). No GM-CFC could be grown
from spleen cells ofthe animals.
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Figure 2. Influence of HQ and PHE at constant concen-
trations of growth factors on FDCP-mix colony forma-
tion in vitro. Colony formation by FDCP-mix cells was
determined in the presence of (A) various concentra-
tions of hydroquinone and a constant concentration of
GM-CSF (50 ng/ml) and IL-3 (0.3 ng/ml); (B) various
concentrations of HQ and a constant concentration of
IL-3 (2% mlL-3-conditioned medium yielding a final
concentration >150 U/ml IL-3); and (C) various equimo-
lar concentrations of HQ + PHE and constant GM-CSF
(50 ng/ml) and IL-3 (0.3 ng/ml). Values are means ±SD
from three independent cultures. Statistically
significant differences from controls using Student's t-
test are indicated, *p<0.01; +p<fl.05.
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EffectofHydroquinone onFormation
ofGranulocyte-Macrophage Colonies
in Vtro
When HQwas present at noncytotoxic con-
centrations, the number of GM colonies
formed by FDCP-mix cells was enhanced
about 2-fold, ifeither GM-CSF or IL-3 was
used as the cytokine driving colony growth
(Figure 2A,B). When PHE was present at
equimolar concentrations in addition to
HQ, a left shift ofthe dose-response curve
ofHQby 2 to 3 logs was observed (Figure
2C). Addition of PHE to HQ-containing
cultures did not result in toxicity at con-
centrations as high as 106M. Variation of
GM-colony stimulating factor (CSF) con-
centrations at constant levels ofHQdid not
affect the ability ofHQ to elicit enhanced
colony formation at both plateau and also
non-saturating cytokine concentrations
(Figure 3). This suggests synergistic inter-
action of HQ and PHE with either
GM-CSF or IL-3.
Discussion
We observed an increase in total GM-CFC
in the bone marrow of mice treated with
HQ or an equimolar mixture of HQ and
PHE. Snyder et al (18) reported the pres-
ence ofincreased numbers ofGM-CFC in
animals that inhaled benzene chronically.
The results of the present study indicate
that this effect may be mediated by the
metabolite HQ. It cannot be determined,
however, if HQ itself, or metabolic prod-
ucts of HQ, such as BQ or trans-trans-
mucondialdehyde, are the moieties that
ultimately act on the GM-CFC. A bias also
remains with regard to the comparability of
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Figure 3. Influence of GM-CSF at constant concentra-
tions of HQ on FDCP-mix colony formation in vitro.
Colony formation by FDCP-mix cells at 1 pM HQ (e), or
untreated cells (o) at varying concentrations of
GM-CSF, and a constant concentration of IL-3 (0.3
ng/ml). Values are means ± standard deviation from
three cultures.
the concentrations ofthe substances reached
in vivo between the benzene inhalation pro-
tocol and the HQ + PHE injection proto-
col; this is because direct measurements of
bone marrow levels ofPHE, HQ, and their
metabolites have not been determined for
the latter protocol. A relative comparability
may be deduced from the fact that the
doses ofHQ and PHE injected are able to
reproduce the bone marrow toxicity that is
achieved by inhalation ofbenzene for the
same interval (20).
In previous experiments (R Henschler
and CM Heyworth, unpublished data),
instead ofan expected change ofdifferenti-
ation pattern upon exposure to HQ, we
noted an increase in cell numbers in liquid
cultures of murine progenitor cell FDCP-
mix that had been induced to differentiate
into the GM lineage. When FCDP-mix
cells were subsequently analyzed in colony
assays, a profound increase in colony num-
bers was observed in the presence of HQ.
Because colony assays of FDCP-mix cells
used as few as 5000 cells/ml, the resulting
increase in colony formation in these assays
is most likely a direct effect of HQ and
GM-CSF on the colony-forming cells and
not an indirect effect via bystander cells.
These studies demonstrate that FDCP-mix
cells retain the capability ofprimary bone
marrow cells to reproduce the synergistic
effect of GM-CSF and HQ, or HQ and
PHE, on myeloid colony formation, as
reported by Irons et al. (19) for unfraction-
ated bone marrow or bone marrow cells
enriched for primitive populations. As
FDCP-mix cells are multipotential cells,
however, and as the primary populations
used by Irons et al. (19) also contain sub-
stantial numbers ofmultipotential precur-
sors in addition to GM-CFC, it is possible
that HQ and GM-CSF act on a multipo-
tential precursor ofGM-CFCs rather than
on GM-CFCs themselves. They may
induce these "pre-GM-CFCs" to undergo
extra cell divisions to yield increased num-
bers of GM-CFC. Another possibility is
that HQ and GM-CSF counteract, for
example, an apoptotic mechanism that
normally results in cell death ofa propor-
tion of potential colony-forming cells.
Additional work will be necessary to eluci-
date the mechanisms underlying the syner-
gism between hematopoietic growth factors
and benzene metabolites.
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